BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dupixent Discussions - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.dupixentdiscussions.com
X-WR-CALDESC:Events for Dupixent Discussions
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251113T121500
DTEND;TZID=America/Los_Angeles:20251113T131500
DTSTAMP:20260408T105723
CREATED:20250829T203319Z
LAST-MODIFIED:20250926T005521Z
UID:10000740-1763036100-1763039700@www.dupixentdiscussions.com
SUMMARY:A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation by Raffi Tachdjian\, MD
DESCRIPTION:Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation[gravityform id=”1″ field_values=”zoomid=97597438455″]
URL:https://www.dupixentdiscussions.com/event/a-treatment-option-for-appropriate-patients-with-skin-diseases-driven-in-part-by-type-2-inflammation-by-raffi-tachdjian-md/
LOCATION:Virtual (Zoom)
CATEGORIES:Chronic Spontaneous Urticaria (CSU)
ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/08/Raffi-Tachdjian-1-e1705692089736-CmAgJG.png
END:VEVENT
END:VCALENDAR